Search Results - "Bolaño, C."

Refine Results
  1. 1

    O04 Myoguide.org: a web-based portal supporting the analysis of MRIs for the diagnosis of neuromuscular patients by Diaz, C Bolaño, Diaz, J Verdu, Chamorro, A Gonzalez, Veeranki, G., Llauger, J., Manera, J Diaz

    Published in Neuromuscular disorders : NMD (01-10-2023)
    “…Muscle magnetic resonance imaging (MRI) is a useful tool to study muscle structure in patients with genetic neuromuscular diseases (NMDs), as it can easily…”
    Get full text
    Journal Article
  2. 2

    P123 MRI based criteria to differentiate dysferlinopathies from other genetic muscle diseases by Diaz, C Bolaño, Verdu-Diaz, J., Gonzalez-Chamorro, A., Straub, V., Manera, J Diaz

    Published in Neuromuscular disorders : NMD (01-10-2023)
    “…Muscle MRI is a useful tool for the diagnosis of neuromuscular diseases as it identifies selective patterns of pathology that are characteristic of a specific…”
    Get full text
    Journal Article
  3. 3

    674P Quantification of skeletal muscle glycogen in late onset Pompe patients using carbon MR spectroscopy at 3 Tesla by Chamorro, A. Gonzalez, Wilson, I., Bolaño, C., Hollingsworth, K., James, M., Wong, K., Fitzsimmons, S., Diaz Manera, J., Thelwall, P.

    Published in Neuromuscular disorders : NMD (01-10-2024)
    “…Pompe disease is a rare genetic disorder resulting from a deficiency of the enzyme alpha-glucosidase. Late onset Pompe patients (LOPD) develop slowly…”
    Get full text
    Journal Article
  4. 4

    P124 A series of dysferlinopathy patients showing fluctuations in muscle fat fraction and contractile cross-sectional area values (cCSA) over a 3-year follow-up period by Diaz, C Bolaño, Wilson, I., Borland, H., de Almeida Araujo, E Caldas, Manera, J Diaz, Straub, V.

    Published in Neuromuscular disorders : NMD (01-10-2023)
    “…Dysferlinopathy is produced by mutations in the DYSF gene causing loss of dysferlin expression leading to progressive muscle weakness. Patients show different…”
    Get full text
    Journal Article
  5. 5

    281P Prognostic significance of ACTN3 genotype in Duchenne muscular dystrophy: findings from an Argentine patient cohort by Luce, L., Mazzanti, C., Carcione, M., Massini, C. Llames, Buonfiglio, P., Dalamón, V., Díaz, C. Bolaño, Mesa, L., Dubrovsky, A., Cotignola, J., Giliberto, F.

    Published in Neuromuscular disorders : NMD (01-10-2024)
    “…A wide phenotypic spectrum exists among DMD patients, with genetic modifiers seen as a putative cause of this variability. The main aim was to evaluate the…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Effects of buspirone on influenza A virus infection in stressed mice by Freire-Garabal, M, Núñez, M J, Losada, C, Pereiro, D, Castro-Bolaño, C, Gándara, J, Varela-Patiño, M P, Rey-Méndez, M

    Published in Life sciences (1973) (1995)
    “…Experiments were conducted to evaluate the effects of chronic buspirone (1 mg/kg/day) on the influenza A (PR-8/34) virus specific immune injury in CD-1 mice…”
    Get more information
    Journal Article
  12. 12

    Allelopathic Effects of Tree Species on Some Soil Microbial Populations and Herbaceous Plants by Souto, X.C., Bolaño, J.C., González, L., Reigosa, M.J.

    Published in Biologia plantarum (01-01-2001)
    “…The allelopathic potential of four tree species on soil microbial populations and some herbaceous plants (two understory species and one general biotest…”
    Get full text
    Journal Article
  13. 13

    655P Predictive modelling of dysferlinopathy progression: a longitudinal fat fraction analysis by Diaz, C. Bolano, Wilson, I., Hilsden, H., James, M., Araujo, E., Reyngoudt, H., Blamire, A., Carlier, P., Straub, V., Manera, J. Diaz

    Published in Neuromuscular disorders : NMD (01-10-2024)
    “…Skeletal muscle quantitative muscle magnetic resonance imaging (MRI) is sensitive to changes in fat content over time. The Dysferlinopathy Clinical Outcome…”
    Get full text
    Journal Article
  14. 14

    P122 Longitudinal Dixon Magnetic Resonance Imaging in dysferlinopathy patients can provide a powerful tool in assessing outcomes of therapeutic interventions by Wilson, I., Reyngoudt, H., Diaz, C Bolano, Araujo, E., Moore, U., Hilsden, H., Manera, J Diaz, Straub, V., Carlier, P., Blamire, A.

    Published in Neuromuscular disorders : NMD (01-10-2023)
    “…Fat replacement in muscles measured by Dixon MRI provides an excellent marker for disease progression in dysferlinopathy patients. Although no specific…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    653P Rapid quantitative assessment of sodium dynamics after exercise using 23Na-MRI in dysferlinopathy and healthy controls by Diaz, C. Bolano, Neal, M., Richardson, M., Muni Lofra, R., Michell-Sodhi, J., James, M., Mayhew, A., Hilsden, H., Wilson, I., Hollingsworth, K., Blamire, A., Straub, V., Thelwall, P., Diaz-Manera, J.

    Published in Neuromuscular disorders : NMD (01-10-2024)
    “…Dysferlin plays a key role in cell membrane repair, and its absence or malfunction in patients with dysferlin-deficient limb girdle muscular dystrophy leads to…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20